Alpha Tau Medical Ltd. current report, Q2 FY2025

Alpha Tau Medical Ltd. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K was filed by Alpha Tau Medical Ltd. on May 12, 2025, covering the month of May 2025. The filing serves to disseminate a press release regarding a corporate governance update.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.

Material Changes

The material change disclosed is the appointment of Nadav Kidron to the Company's Board of Directors, as announced in the press release dated May 12, 2025.

Guidance, Outlook, and Risks

The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. The document explicitly states that the information furnished is not deemed "filed" for purposes of Section 18 of the Exchange Act.

Key Facts for Investors

  • Nadav Kidron has been appointed to the Board of Directors.
  • The filing is a current event report (Form 6-K) and does not include financial results.
  • The press release is attached as Exhibit 99.1.